Affinity Biosensors Revenue and Competitors
Estimated Revenue & Valuation
- Affinity Biosensors's estimated annual revenue is currently $4.5M per year.
- Affinity Biosensors's estimated revenue per employee is $155,000
Employee Data
- Affinity Biosensors has 29 Employees.
- Affinity Biosensors grew their employee count by 4% last year.
Affinity Biosensors's People
Name | Title | Email/Phone |
---|
Affinity Biosensors Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Affinity Biosensors?
Affinity Biosensors develops and manufactures award-winning analytical instruments for use in research, manufacturing, and life sciences. Instruments are based on the Company’s exclusive Resonant Mass Measurement (RMM) technology. The sensor is a MEMS-fabricated sensor, enabling the measurement of mass in fluid, with femtogram resolution. The LifeScale instrument is the current state-of-the-art system to exploit Resonant Mass Measurement technology leading to new, unique and rapid techniques for the measurement and observation of microbe growth and response. RAPID and PRECISE COUNTS and MASS MEASUREMENT OF INDIVIDUAL MICROBES LOW SAMPLE VOLUME AND CONCENTRATIONS SIMPLE SAMPLE PREPARATION QUANTITATIVE RESULTS SIMPLE TOUCH-SCREEN SOFTWARE RAPID RESULTS LifeScale AST A well-plate format for rapid (3-3.5 hours) antibiotic susceptibility testing of Gram-negative rods. The semi-automated platform offers high throughput, and excellent statistics. The LifeScale system gives the fastest possible assessment of microbial growth. Performance in antibiotic susceptibility testing has been validated on clinically derived organisms direct from positive blood culture using a custom antibiotic panel. The LifeScale-AST is CE Marked (IVDD 98/79/EC).
keywords:N/AN/A
Total Funding
29
Number of Employees
$4.5M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.1M | 29 | 7% | $5.8M |
#2 | $3.9M | 29 | 38% | N/A |
#3 | $4.2M | 29 | 0% | N/A |
#4 | $4.5M | 29 | 0% | N/A |
#5 | $1.7M | 29 | -3% | N/A |